Jorge Berlanga

933 total citations
33 papers, 728 citations indexed

About

Jorge Berlanga is a scholar working on Rehabilitation, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jorge Berlanga has authored 33 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rehabilitation, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Jorge Berlanga's work include Wound Healing and Treatments (7 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Animal Genetics and Reproduction (4 papers). Jorge Berlanga is often cited by papers focused on Wound Healing and Treatments (7 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Animal Genetics and Reproduction (4 papers). Jorge Berlanga collaborates with scholars based in Cuba, United Kingdom and Spain. Jorge Berlanga's co-authors include Hussam Ajamieh, Pedro López‐Saura, Nelsón Merino, Isabel Guillén, Lamberto Re, Raymond J. Playford, Danay Cibrián, Freya Freyre, José de la Fuente and Naila Ahmed and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal Of Pathology and Clinical Science.

In The Last Decade

Jorge Berlanga

33 papers receiving 689 citations

Peers

Countries citing papers authored by Jorge Berlanga

Since Specialization

Citations

This map shows the geographic impact of Jorge Berlanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Berlanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Berlanga more than expected).

Fields of papers citing papers by Jorge Berlanga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Berlanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Berlanga. The network helps show where Jorge Berlanga may publish in the future.

Co-authorship network of co-authors of Jorge Berlanga

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Berlanga. A scholar is included among the top collaborators of Jorge Berlanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Berlanga. Jorge Berlanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroprotective effect of epidermal growth factor in experimental acrylamide neuropathy: an electrophysiological approach 2017 ·Journal of the Peripheral Nervous System ·(unknown), (unknown), Jorge Berlanga, (unknown), (unknown)	8
2	Assessment of dose–effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy 2015 ·Neurological Research ·(unknown), (unknown), Jorge Berlanga, (unknown), (unknown), Claire L. Gibson, (unknown)	6
3	Heberprot-P: A Novel Product for Treating Advanced Diabetic Foot Ulcer 2013 ·MEDICC Review ·Jorge Berlanga, (unknown), Ernesto López‐Morales, Pedro Benito López, (unknown), Carmen Valenzuela, (unknown), Verena Muzio, (unknown), Ricardo Pereira Silva, Boris Acevedo, Luís Herrera, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	20
4	Effect of human epidermal growth factor on the tumor cell line A431: in vivo analysis of tumor growth inhibition and gene expression 2012 ·SHILAP Revista de lepidopterología ·Isabel Guillén, (unknown), (unknown), (unknown), (unknown), María Elena Ochagavia, (unknown), (unknown), (unknown), (unknown), (unknown), Julio R. Fernández, (unknown), Karelia Cosme, Gerardo Guillén, Luís Herrera, Jorge Berlanga, (unknown)	2
5	Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers 2012 ·European Journal of Pharmaceutical Sciences ·Ania Cabrales, Jeovanis Gil, Eduardo Fernández, Carmen Valenzuela, Francisco Hernández‐Bernal, (unknown), (unknown), Vladimir Besada, Osvaldo Reyes, Gabrìel Padrón, Jorge Berlanga, Gerardo Guillén, Luis Javier González	9
6	Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis 2011 ·Restorative Neurology and Neuroscience ·(unknown), Enrique Montero, (unknown), (unknown), (unknown), (unknown), (unknown), Jorge Berlanga	13
7	Heberprot-P: antecedentes experimentales y bases farmacológicas 2010 ·Biotecnología aplicada ·Jorge Berlanga	4
8	Therapeutic Effect of the Combined Use of Growth Hormone Releasing Peptide-6 and Epidermal Growth Factor in an Axonopathy Model 2010 ·Neurotoxicity Research ·(unknown), (unknown), Valia Rodrı́guez, Javier Marín, Viviana Falcón, Jorge Martı́n, Danay Cibrián, Jorge Berlanga	18
9	Efecto citoprotector cardíaco y extracardíaco del péptido GHRP6 2008 ·Biotecnología aplicada ·Danay Cibrián, Jorge Berlanga, (unknown), (unknown), Gerardo Guillén, (unknown), (unknown), Viviana Falcón, (unknown)	3
10	Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice 2005 ·Neuroscience Letters ·Jorge Aguiar, Julio R. Fernández, (unknown), Yssel Mendoza‐Marí, (unknown), José Antonio Suárez, Jorge Berlanga, (unknown), Gerardo Guillén, Luís Herrera, Luís Velázquez, (unknown), Nelsón Merino	36
11	Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion 2005 ·Transplant International ·Hussam Ajamieh, Jorge Berlanga, Nelsón Merino, Gregorio Martı́nez-Sánchez, (unknown), Silvia Menéndez Cepero, (unknown), Lamberto Re, Olga Sonia León	63
12	Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds 2005 ·Clinical Science ·Jorge Berlanga, Danay Cibrián, Isabel Guillén, Freya Freyre, (unknown), Pedro López‐Saura, Nelsón Merino, (unknown), Ana María Quintela, (unknown), (unknown), Hussam Ajamieh, (unknown), Naila Ahmed, Paul J. Thornalley	135
13	Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents 2002 ·Burns ·Jorge Berlanga, (unknown), Pedro López‐Saura	16
14	Prophylactic Use of Epidermal Growth Factor Reduces Ischemia/Reperfusion Intestinal Damage 2002 ·American Journal Of Pathology ·Jorge Berlanga, (unknown), Diadelis Remírez, Ricardo González, Pedro López‐Saura, Jorge Aguiar, Miriam Ojeda Ojeda, Joseph J. Boyle, Anthony J. Fitzgerald, Raymond J. Playford	67
15	Disposition and receptor‐site binding of ¹²⁵I‐EGF after topical administration to skin wounds 2002 ·Biopharmaceutics & Drug Disposition ·(unknown), Jorgé Duconge, Carmen Valenzuela, Jorge Berlanga, (unknown), (unknown)	17
16	Transfection of intact and wounded skin with a DNA/polyethylenimine complex 2000 ·Biotecnología aplicada ·Jorge Berlanga, (unknown), (unknown), (unknown), Ricardo Lleonart, Fidel Ovídio Castro	1
17	Consideraciones acerca del papel del factor de crecimiento epidérmico en la protección celular y tisular 1999 ·Medicina Clínica ·Jorge Berlanga, Enrique Caballero, (unknown), (unknown), Raymond J. Playford	2
18	Epidermal growth factor stimulated re-epithelization in pigs. The possible role of acute-wound proteases 1998 ·Biotecnología aplicada ·Jorge Berlanga, (unknown), Osvaldo Reyes, (unknown), (unknown)	2
19	Etiología nutro-viral de la neuropatía epidémica 1998 ·Revista cubana de medicina tropical ·Maria Pilar Rodríguez, Jorge Berlanga, (unknown)	2
20	Evaluation in animal models of the neurovirulence of isolates from patients with epidemic neuropathy 1994 ·Biotecnología aplicada ·Fidel Ovídio Castro, Jorge Berlanga, (unknown), (unknown), (unknown), (unknown), (unknown), Manuel Avelino Pestano Pérez, (unknown), (unknown), María Claudia López, Luís Herrera, José de la Fuente	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact